415 articles by Jonathan Gardner
-
Pfizer, BioNTech are first to seek full FDA approval of a coronavirus vaccine
May 7, 2021 -
Pharma erupts as Biden administration backs waiver of vaccine patent rights
May 6, 2021 -
Dyno, in demand for its gene therapy work, raises $100M for fast expansion
May 6, 2021 -
Esker, a new biotech startup, launches with plans to make targeted immune drugs
May 5, 2021 -
Sarepta's second-gen Duchenne drug shows signs of topping its first
May 3, 2021 -
Denying problems, AstraZeneca says US coronavirus vaccine filing due within weeks
April 30, 2021 -
Moderna plans to triple coronavirus vaccine production next year
April 29, 2021 -
Lilly, citing FDA feedback, won't seek speedy approval of Alzheimer's drug
April 27, 2021 -
FDA lifts hold on UniQure gene therapy study after review of cancer case
April 26, 2021 -
A look ahead at the FDA meeting that could decide the future of 6 cancer drug approvals
April 22, 2021 -
J&J to resume vaccine rollout in Europe after regulator says benefits outweigh risks
April 20, 2021 -
Positive data in hand, TG Therapeutics readies MS drug for FDA review
April 19, 2021 -
US clears AstraZeneca buyout of Alexion amid closer scrutiny of biopharma M&A
April 16, 2021 -
CDC panel delays decision on J&J vaccine, extending pause over rare side effect
April 14, 2021 -
The US paused use of J&J's vaccine. What happens next?
April 13, 2021 -
Cavazzoni to succeed Woodcock as the FDA's top drug reviewer
April 12, 2021 -
Sage, Biogen drug reduces tremors but side effects could limit potential
April 12, 2021 -
Pfizer, BioNTech's vaccine protects 12- to 15-year-olds from COVID-19 in study
March 31, 2021 -
5 FDA approval decisions to watch in the second quarter
March 29, 2021 -
Bristol Myers gets late-stage win in test of new type of immunotherapy
March 25, 2021 -
Roche stops giving Huntington's disease drug in closely watched study
March 23, 2021 -
Roche immunotherapy notches a win in early lung cancer, pressuring Merck
March 22, 2021 -
With new results, Sarepta's 2nd gene therapy holds steady
March 19, 2021 -
Gilead, still aiming at NASH, broadens an alliance with Novo
March 18, 2021 -
FTC joins overseas antitrust regulators in reexamination of pharma M&A
March 16, 2021